Kliphouse Kirsten Marie 4

What Happened Kirsten Marie Kliphouse, a director of Labcorp Holdings Inc. (LH), received a grant of 773 restricted stock units (RSUs) on February 10, 2026. The RSUs were reported as acquired at $0.00 (no purchase price); each RSU represents the contingent right to one share of Labcorp common stock and will convert to shares if and when the units vest. This was an award/compensation grant, not a purchase or sale.

Key Details

• Transaction date: 2026-02-10; Form 4 filed 2026-02-12 (timely filing, two business days after the transaction).
• Grant: 773 RSUs, acquisition price reported as $0.00 (derivative award).
• Vesting: The RSUs vest in full on February 10, 2027 (one-year cliff) (Footnote F2).
• Holdings after transaction: 773 RSUs reported as the aggregate number held by the reporting person (Footnote F3).
• Notes: Each RSU equals the right to one share upon vesting (Footnote F1). Exhibit 24 (Power of Attorney) appended.

Context RSU grants are a common form of executive/director compensation and do not indicate an immediate purchase or sale of shares. The economic value of these RSUs will depend on Labcorp’s share price at the vesting date; tax withholding or other conditions may apply when units vest and shares are delivered.